22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes
25 févr. 2022 09h51 HE
|
22nd Century Group, Inc
FDA’s Rulemaking Process Could Make VLN® Menthol King Reduced Nicotine Cigarettes the Only Menthol Cigarette on the Market Opportunity to Accelerate FDA’s Plan to Cap Nicotine in Cigarettes at Levels...
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
23 févr. 2022 08h00 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Secures USDA Organic Certification for Needle Rock Farms
10 févr. 2022 11h30 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
03 févr. 2022 09h20 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
01 févr. 2022 12h30 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 01, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
26 janv. 2022 11h00 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Appoints James A. Mish to Its Board of Directors
21 janv. 2022 08h00 HE
|
22nd Century Group, Inc
BUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and...
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
18 janv. 2022 08h00 HE
|
22nd Century Group, Inc
FDA Mandates Addition of Extra Claim “Helps You Smoke Less” on PackagingU.S. Pilot Market Launch with Major Retail Partner by March 2022 BUFFALO, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- On December...
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
03 janv. 2022 14h23 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
La FDA autorise la commercialisation des cigarettes VLN® de 22nd Century Group en tant que produit du tabac à risque modifié
29 déc. 2021 06h31 HE
|
22nd Century Group, Inc
VLN® est la première et la seule cigarette combustible au monde à recevoir la désignation MRTP de la FDALa FDA ajoute une allégation principale fondée sur des preuves « Vous aide à fumer moins » aux...